(Q37633169)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19914533%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

review article

1 reference

title

Lessons on responsiveness to adjuvant systemic therapies learned from the neoadjuvant setting (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19914533%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19914533%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

2

Giuseppe Viale

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19914533%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Aron Goldhirsch

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19914533%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

1 October 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19914533%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19914533%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

18 Suppl 3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19914533%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

S137-40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19914533%20AND%20SRC:MED&resulttype=core&format=json

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

12 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Breast tumour response to primary chemotherapy predicts local and distant control as well as survival

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Annual hazard rates of recurrence for breast cancer after primary therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Pathologic features of breast cancer associated with complete response to neoadjuvant chemotherapy: importance of tumor necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial: multivariate analysis with Ki-67 index, mitotic count, and microvessel density

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Prognostic relevance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Is Nottingham prognostic index useful after induction chemotherapy in operable breast cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2809%2970289-9

7 January 2021

10.1016/S0960-9776(09)70289-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19914533%20AND%20SRC:MED&resulttype=core&format=json

release_bljraejevbfindvx5fgpi53wh4

12 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bljraejevbfindvx5fgpi53wh4

24 November 2022

mapped directly with Wikidata item

1 reference